Brought to you by 
VI Technologies acquires Pentose Pharmaceuticals
10 Apr 2001
Executive Summary
VI Technologies Inc. (Vitex) will acquire privately held viral inactivation company Pentose Pharmaceuticals Inc. in an all-stock transaction valued at about $45mm. The merger is expected to be completed in the fourth quarter of 1999.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com